PSI Events

Structured Benefit-Risk Assessment – Methodology and Practice

  • Dates: 08 – 09 Mar, 2016
  • How to find us: Hilton Garden Inn, Heathrow, UK
The aim of this workshop is to provide participants an understanding of structured benefit-risk assessments, and the regulatory requirements on benefit-risk assessment within the EU. The 2 day course includes a practical workshop whereby participants will critically evaluate the benefit-risk balance of medicinal and healthcare product(s) in a robust and transparent manner. The course will provide participants the opportunity to gain insight and develop modelling skills in benefit-risk assessment, with an emphasis on multi-criteria decision analysis.

Structured Benefit-Risk Assessment – Methodology and Practice - Flyer 
 
 The following topics will be covered:
  • Regulatory issues surrounding benefit-risk (BR) assessment
  • Planning a structured BR assessment
  • BR assessment methodologies
  • Making the right methodology choices
  • The involvement of multiple stakeholders in a BR assessment
  • BR assessment in regulatory submissions
  • Quantitative modelling in BR assessment
  • Modelling benefit-risk balance and uncertainty involving multiple stakeholders
  • Application and issues of BR assessment in health technology assessments

 
Lecturers taken from academia and industry with an involvement in the IMI PROTECT Initiative on Benefit-Risk Assessment and industry group’sown initiatives. 
Keynote speakers include Prof Deborah Ashby (Imperial College) and Prof Larry Phillips (London School of Economics).

Course runs from: 12:00 – 18.30 (registration from 10:00) on Day 1 and 
   09:00 – 16:30 on Day 2.

 

Registration
PSI Members £495 plus VAT 
Non - members £570 plus VAT (includes PSI membership for 1 year)
Academic £295 plus VAT 

Registration costs (includes lunch and refreshments)

Registration for this 2 day course is now closed.

PSI aims to be fully inclusive and endeavours to accommodate delegates with disabilities wherever possible.  Please help us to help you by letting us know if you require additional facilities or have any special requirements.  Please contact us on +44 (0)1730 715 235 or at PSI@mci-group.com for further information.

Latest News


  • EMA, ICH and FDA documents for review

    EMA "Draft guideline on strategies to identify and mitigate risks for first-in-human and early clinical trials with investigational medicinal products", ICH E17 and FDA ("Non-Inferiority Clinical Trials") new draft documents.
    more»
  • The ACE Project

    The ACE Project aims to develop a consensus driven reporting guidance tailored for ADs in the form of a CONSORT extension. We hope this will enhance transparency, credibility, reproducibility, and replicability of adaptive trials. The hope would be to facilitate uptake of ADs in clinical trials research when appropriate.
    more»
Show all news
PAREXEL Logo with Tagline (Print Version, CMYK)

SENIOR/PRINCIPAL BIOSTATISTICIAN

read more...

Novartis Image

Senior Principal Statistical Scientist

read more...

inventiv health logo2

Principal Statistician

read more...

celgene%20pms%20280%20rgb%20600ppi_jpg

Principal Statistician

read more...

OUS_logo

Researcher/Professor

read more...

Watton-Hall-logo

Senior Principal Biostatistician

read more...

Watton-Hall-logo

Global Head Biostatistics

read more...